EHTH
eHealth, Inc.
There isn't enough reported data to score EHTH yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
EHTH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
EHTH's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like EHTH.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
EHTH PE Valuation
EHTH has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
EHTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect EHTH's earnings to grow and its profitability to improve, but its revenue to decline.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over EHTH on the outlook, with more favorable revenue expectations.
EHTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q4 2024 | -$1.19 | +$1.18 |
| Q3 2024 | -$2.62 | +$0.78 |
| Q2 2024 | -$2.47 | +$0.97 |
| Q1 2024 | -$2.32 | +$1.59 |
| Q4 2023 | -$2.37 | +$1.99 |
| Q3 2023 | -$3.40 | +$2.89 |
| Q2 2023 | -$3.44 | +$3.37 |
| Q1 2023 | -$3.91 | +$2.11 |
JPM has the stronger earnings trend. Trailing diluted EPS is down 150% for EHTH versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
EHTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.3M | -60% |
| Q2 2026 | $33.6M | -45% |
| Q1 2026 | $88M | -22% |
| Q4 2025 | $326.2M | +3.5% |
| Q3 2025 | $53.9M | -7.8% |
| Q2 2025 | $60.8M | -7.7% |
| Q1 2025 | $113.1M | +22% |
| Q4 2024 | $315.2M | +27% |
EHTH's revenue is shrinking: $21M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -218% | -141 points |
| Q2 2026 | -82% | -44 points |
| Q1 2026 | -3.3% | -7.5 points |
| Q4 2025 | 39% | +3 points |
| Q3 2025 | -77% | -3.1 points |
| Q2 2025 | -38% | +4.5 points |
| Q1 2025 | 4.2% | +24 points |
| Q4 2024 | 36% | +12 points |
EHTH's operating margin was −218% last quarter, down 141 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over EHTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over EHTH on profitability, with a higher operating margin.
EHTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.3M | +$14.3M |
| Q2 2026 | -$5.4M | +$37.3M |
| Q1 2026 | $35.6M | -54% |
| Q4 2025 | -$36.1M | -$7.8M |
| Q3 2025 | -$25.5M | +$4.8M |
| Q2 2025 | -$42.8M | -$10.3M |
| Q1 2025 | $76.8M | +8.9% |
| Q4 2024 | -$28.3M | +$5.4M |
EHTH has the edge over JPM on cash flow, with more consistent year-over-year improvement.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
EHTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +353K shares |
| 1 year | +5.7% | +1.7M shares |
| 3 years | +16% | +4.5M shares |
| 5 years | +21% | +5.5M shares |
| Available history | +31% | +7.6M shares |
EHTH has 32M diluted shares, up 5.7% from a year ago.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over EHTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
EHTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | 0.8x | Very low |
EHTH's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like EHTH.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over EHTH on leverage, with a lower net debt burden relative to earnings.
EHTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 1.6 | Oversold |
EHTH's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
EHTH PE vs Financial Services Sector
| Metric | EHTH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EHTH has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
EHTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.58 | 24% below |
| 20 week MA | $0.99 | 56% below |
| 50 week MA | $1.79 | 75% below |
| 100 week MA | $3.78 | 88% below |
| 200 week MA | $5.21 | 92% below |
EHTH is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over EHTH on trend strength, trading above more of its moving averages.
EHTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.4 | $73.9 | -22% |
| 2021 | $73.9 | $26.9 | -64% |
| 2022 | $26.9 | $4.43 | -84% |
| 2023 | $4.43 | $8.72 | +97% |
| 2024 | $8.72 | $8.65 | -0.8% |
| 2025 | $8.65 | $4.12 | -52% |
| 2026 YTD | $4.12 | $0.44 | -89% |
EHTH has finished lower in five of the last six years. It's down 89% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over EHTH on returns for 2026, with the stronger performance.